Stimwave’s Pain Management Devices Win Reimbursement Authorization in Germany

Pompano Beach, Fla.-based Stimwave Technologies said it has received additional public health insurance reimbursement authorization for its chronic pain management devices in Germany, one of the company’s largest markets outside of the U.S.

Germany’s Institute for the Hospital Remuneration System has granted the company’s Freedom peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) devices a “Status 1” designation, which allows hospitals to negotiate additional reimbursement.

The new designations are “based on [the institute’s] belief that Stimwave Technologies’ chronic pain management products are innovative medical devices that previously lacked sufficient payment,” the company said.

The Freedom PNS and Freedom SCS devices have received CE marks as well as FDA 510(k) clearances.